Barisani et al. found an inadequate hepcidin production for a given level of iron status in NAFLD patients compared to controls, although not as low as in beta-thalassemia or hereditary hemochromatosis [11]. The gene discussed is HAMP; the disease is metabolic dysfunction-associated steatotic liver disease.